Notices
21 October 2016
21 October 2016
Jean‐François Dufour – 21 October 2016
21 October 2016
Antonella Putignano, Thierry Gustot – 17 October 2016 – Acute‐on‐chronic liver failure (ACLF) is a recently defined syndrome that occurs frequently in patients with cirrhosis and is associated with a poor short‐term prognosis. Currently, management of patients with ACLF is mainly supportive. Despite medical progress, this syndrome frequently leads to multiorgan failure, sepsis, and, ultimately, death. The results of attempts to use liver transplantation (LT) to manage this critical condition have been poorly reported but are promising.
Silvia Sookoian, Carlos J. Pirola – 13 October 2016
Astrid Marot, Hélène Vandenbulcke, Jean‐François Knebel, Christopher Doerig, Christophe Moreno, Pierre Deltenre – 13 October 2016
Shaleen Agarwal, Neerav Goyal, Mohammed Nayeem, Shishir Pareek, Subash Gupta – 12 October 2016 – Living donor liver transplantation (LDLT) in obese patients raises concerns with regards to obtaining grafts of “adequate” graft‐to‐recipient weight ratio (GRWR) and the impact of obesity on the outcomes of LDLT. LDLT outcomes in patients weighing ≥100 kg were compared with those weighing <100 kg. Patients weighing ≥100 kg were divided into 3 categories based on the GRWR of the grafts they received.
Amanda M. Lynn, Michael D. Leise – 12 October 2016
This webinar will review the current state of the understanding of the immune response to hepatitis b (HBV). Two experts and one moderator will guide providers through an understanding of the HBV immune interactions that can help providers understand and help explain HBV infections, guide patient management and help embrace new therapies.Rachel Church (Moderator) Rachel Church, PhD is a Research Assistant Professor in the Department of Pharmacotherapy and Experimental Therapeutics within the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill.
David B. Haslam – 7 October 2016